Literature DB >> 9428002

Phosphorylation of phospholipase C-coupled receptors.

A B Tobin1.   

Abstract

Early work on G-protein-coupled receptor (GPCR) phosphorylation focused on the adenylyl cyclase-linked beta-adrenoceptor, where phosphorylation at sites on the C-terminal tail and within the third intracellular loop results in receptor desensitisation. In recent years, intense research activity has revealed that a large number of GPCR subtypes exist as phosphoproteins, where the level of phosphorylation is dramatically increased subsequent to receptor stimulation. Among these receptor subtypes are those receptors coupled to phospholipase C (PLC). It appears, therefore, that regulation via receptor phosphorylation is a mechanism employed by all but a few GPCRs, including those coupled to PLC. Because the majority of GPCRs are coupled to the phosphoinositide signalling pathway, receptor phosphorylation of PLC-coupled receptors is a regulatory process with profound physiological significance for a huge array of biological responses. This review discusses the properties of homologous and heterologous phosphorylation of PLC-coupled receptors, together with the receptor kinases involved and the functional significance of receptor phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9428002     DOI: 10.1016/s0163-7258(97)00053-3

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  12 in total

Review 1.  The muscarinic M(5) receptor: a silent or emerging subtype?

Authors:  R M Eglen; S R Nahorski
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

Review 2.  Angiotensin and calcium signaling in the pituitary and hypothalamus.

Authors:  Cecilia Suárez; Isabel García Tornadú; Carolina Cristina; Jorge Vela; Arturo González Iglesias; Carlos Libertun; Graciela Díaz-Torga; Damasia Becu-Villalobos
Journal:  Cell Mol Neurobiol       Date:  2002-06       Impact factor: 5.046

3.  Evidence for LHRH-receptor expression in human airway epithelial (Calu-3) cells and its role in the transport of an LHRH agonist.

Authors:  Kavitha Koushik; Nagesh Bandi; Sneha Sundaram; Uday B Kompella
Journal:  Pharm Res       Date:  2004-06       Impact factor: 4.200

Review 4.  Once and future signaling: G protein-coupled receptor kinase control of neuronal sensitivity.

Authors:  Richard T Premont
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

5.  Arrestin 3 mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21.

Authors:  Melissa A Byers; Psachal A Calloway; Laurie Shannon; Heather D Cunningham; Sarah Smith; Fang Li; Brian C Fassold; Charlotte M Vines
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

6.  Agonist-induced desensitization and phosphorylation of m1-muscarinic receptors.

Authors:  M G Waugh; R A Challiss; G Berstein; S R Nahorski; A B Tobin
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

7.  Role of Rac1 in regulation of NOX5-S function in Barrett's esophageal adenocarcinoma cells.

Authors:  Jie Hong; Murray Resnick; Jose Behar; Jack Wands; Ronald A DeLellis; Weibiao Cao
Journal:  Am J Physiol Cell Physiol       Date:  2011-04-27       Impact factor: 4.249

8.  Homologous and heterologous uncoupling of muscarinic M(3) and alpha(1B) adrenoceptors to Galpha(q/11) in SH-SY5Y human neuroblastoma cells.

Authors:  R A Bundey; S R Nahorski
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

9.  Bile acid reflux contributes to development of esophageal adenocarcinoma via activation of phosphatidylinositol-specific phospholipase Cgamma2 and NADPH oxidase NOX5-S.

Authors:  Jie Hong; Jose Behar; Jack Wands; Murray Resnick; Li Juan Wang; Ronald A Delellis; David Lambeth; Weibiao Cao
Journal:  Cancer Res       Date:  2010-01-19       Impact factor: 12.701

10.  Caveolin-1 alters Ca(2+) signal duration through specific interaction with the G alpha q family of G proteins.

Authors:  Parijat Sengupta; Finly Philip; Suzanne Scarlata
Journal:  J Cell Sci       Date:  2008-04-08       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.